Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
28.45
-0.42 (-1.45%)
Nov 20, 2024, 4:00 PM EST - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $796.81 million as of November 21, 2024. Its market cap has increased by 64.50% in one year.
Market Cap
796.81M
Enterprise Value
543.76M
1-Year Change
64.50%
Ranking
Category
Stock Price
$28.45
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $796.81M, an increase of 547.54%. That is a compound annual growth rate of 41.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 796.81M | 37.21% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | 1.62B | 176.41% |
| Dec 31, 2019 | 586.84M | 376.90% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 833.24M |
| Healthcare Services Group | 820.49M |
| Rapport Therapeutics | 808.52M |
| Relay Therapeutics | 803.44M |
| Autolus Therapeutics | 793.04M |
| AbCellera Biologics | 784.20M |
| Cullinan Therapeutics | 783.74M |
| Pliant Therapeutics | 783.49M |